FERRI, GIAN LUCA
 Distribuzione geografica
Continente #
EU - Europa 185.066
NA - Nord America 9.889
AS - Asia 3.600
SA - Sud America 522
AF - Africa 53
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 10
Totale 199.165
Nazione #
IT - Italia 182.364
US - Stati Uniti d'America 9.795
CN - Cina 1.610
SG - Singapore 1.443
UA - Ucraina 862
SE - Svezia 685
BR - Brasile 439
DE - Germania 353
FI - Finlandia 258
GB - Regno Unito 242
VN - Vietnam 178
FR - Francia 123
KR - Corea 102
HK - Hong Kong 64
CA - Canada 54
IN - India 44
RU - Federazione Russa 41
AR - Argentina 33
JP - Giappone 27
NL - Olanda 27
PL - Polonia 24
BD - Bangladesh 22
TR - Turchia 22
AU - Australia 21
MX - Messico 20
ZA - Sudafrica 20
ES - Italia 18
EC - Ecuador 16
BE - Belgio 15
IQ - Iraq 13
CZ - Repubblica Ceca 10
EU - Europa 10
IR - Iran 10
MA - Marocco 10
AT - Austria 9
CL - Cile 9
ID - Indonesia 8
MU - Mauritius 8
IE - Irlanda 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
CH - Svizzera 6
EG - Egitto 6
MY - Malesia 6
PK - Pakistan 6
VE - Venezuela 6
CO - Colombia 5
AE - Emirati Arabi Uniti 4
BB - Barbados 4
CR - Costa Rica 4
JO - Giordania 4
PY - Paraguay 4
RO - Romania 4
UY - Uruguay 4
AL - Albania 3
HU - Ungheria 3
KZ - Kazakistan 3
LT - Lituania 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
OM - Oman 3
PE - Perù 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
BH - Bahrain 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GY - Guiana 2
HN - Honduras 2
TN - Tunisia 2
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
CI - Costa d'Avorio 1
DM - Dominica 1
ET - Etiopia 1
GE - Georgia 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MK - Macedonia 1
MQ - Martinica 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
TM - Turkmenistan 1
Totale 199.165
Città #
Cagliari 179.050
Uta 2.740
Fairfield 1.030
Woodbridge 864
Chandler 784
Ashburn 720
Singapore 685
Houston 676
Ann Arbor 563
Wilmington 510
Boardman 486
Jacksonville 458
Nyköping 430
Seattle 428
Dallas 410
Cambridge 355
Beijing 272
Los Angeles 198
Hefei 165
Dearborn 158
Nanjing 144
Boston 137
Buffalo 135
Shanghai 134
Helsinki 119
Santa Clara 112
Seoul 101
New York 91
Hong Kong 62
The Dalles 62
Dong Ket 58
Milan 57
San Diego 56
Guangzhou 52
Ho Chi Minh City 49
Munich 49
Jiaxing 47
Tianjin 45
Verona 45
Nanchang 42
Chicago 41
São Paulo 41
Shenyang 40
Hebei 36
Redwood City 34
Changsha 33
Phoenix 30
Norwalk 28
Hanoi 27
Rome 27
Orange 26
Toronto 26
Tokyo 23
Mountain View 21
San Mateo 21
Brooklyn 20
Redondo Beach 20
Rio de Janeiro 20
Auburn Hills 18
Belo Horizonte 18
Jinan 18
London 18
Sydney 18
Warsaw 18
Zhengzhou 18
Atlanta 17
Denver 16
Hangzhou 16
Nuremberg 16
Saint Petersburg 15
Frankfurt am Main 14
Johannesburg 14
Falls Church 13
Amsterdam 12
Montreal 12
Council Bluffs 11
Kunming 11
Ningbo 11
Curitiba 10
Düsseldorf 10
Renton 10
Sassari 10
Stockholm 9
Washington 9
Brussels 8
Leawood 8
Manchester 8
Orem 8
Poplar 8
San Francisco 8
Sestu 8
Taizhou 8
Turku 8
Brno 7
Dublin 7
Fuzhou 7
Jinhua 7
Pune 7
San Jose 7
Walnut 7
Totale 193.576
Nome #
VGF peptide profiles in Type 2 diabetic patients' plasma and in obese mice 4.726
VGF protein and its C-terminal derived peptides in amyotrophic lateral sclerosis: Human and animal model studies 4.723
Photoperiod Regulates vgf-Derived Peptide Processing in Siberian Hamsters 4.318
Profiles of VGF peptides in the rat brain and their modulations after Phencyclidine treatment 4.037
Involvement of nigral oxytocin in locomotor activity: a behavioral, immunohistochemical and lesion study in male rats 4.019
Targeting Substantia Nigra through Oxytocin Receptors. 3.828
VGF: an inducible gene product, precursor of a diverse array of neuro-endocrine peptides and tissue-specific disease biomarkers. 3.826
VGF and Type II Diabetes: Decrease of VGF fragment levels in adipose tissues of diet-induced obese mice 3.814
Selective expression of TLQP-21 and other VGF peptides in gastric neuroendocrine cells and modulation by feeding 3.800
Parkinson’s disease: changes in TLQP and related peptide/s in 6-OHDA treated rat and in human plasma 3.698
VGF-peptides in the Siberian hamster 3.655
Hypothalamic over-expression of VGF in the Siberian hamster increases energy expenditure and reduces body weight gain 3.618
Distribution of VGF peptides in the human cortex and their selective changes in Parkinson's and Alzheimer's diseases 3.543
VGF peptides: differential expression in motor neurons, and possible changes in Amyotrophic Lateral Sclerosis (ALS). 3.541
A multidisciplinary approach to mental illness: Do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders 3.469
Selective expression of vgf-derived peptides in gastric endocrine cells: differential modulation of TLQP-peptides by feeding 3.390
VGF changes during the estrous cycle: a novel endocrine role for TLQP peptides? 3.318
Reduction of Total Brain and Cerebellum Volumes Associated With Neuronal Autoantibodies in Patients With APECED 3.169
Neuroendocrine regulatory peptide-1 and neuroendocrine regulatory peptide-2 influence differentially feeding and penile erection in male rats: sites of action in the brain 3.166
VGF peptides in hypothalamus-pituitary axis in the rat estrous cycle 3.160
Attività motoria e interazione tra ossitocina, dopamina ed acido glutammico nella Sostanza Nera del ratto maschio: uno studio comportamentale, immunoistochimico e di lesione 3.141
Differential distribution of VGF-derived peptides in the adrenal medulla and evidence for their selective modulation 3.127
Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment 3.100
Oxytocin induces penile erection when injected into the ventral subiculum: role of nitric oxide and glutamic acid 3.047
TLQP peptides in amyotrophic lateral sclerosis: possible blood biomarkers with a neuroprotective role 2.897
A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation 2.844
Novel neuronal and endocrine autoantibody targets in autoimmune polyendocrine syndrome type 1 2.842
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications 2.831
Targeting Substantia Nigra through Oxytocin Receptors 2.692
VGF peptides as novel biomarkers in Parkinson’s disease 2.674
null 2.647
Oxytocin injected into the ventral tegmental area induces penile erection and increases extracellular dopamine in the nucleus accumbens and paraventricular nucleus of the hypothalamus of male rats 2.602
Modulation of the VGF derived peptides NERP-1 and –2 upon salt loading and dehydration: novel actors in water homeostasis? 2.559
Oxytocin induces penile erection when injected into the ventral tegmental area of male rats: role of nitric oxide and cyclic GMP 2.440
VGF peptides and peripheral activation of energy expenditure 2.417
VGF metabolic-related gene: distribution of its derived peptides in mammalian pancreatic islets 2.333
Multiple immunofluorescence technology 2.321
TLQP 21 and other Pro-VGF peptides: peripheral and central alternative peptide products from the neuro-endocrine vgf gene and evidence for their modulation. 2.313
The hypothalamic-pituitary axis and autoantibody related disorders 2.269
Alzheimer’s disease related vgf-peptide/s in the mammalian nervous system 2.252
VGF Peptides in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies 2.168
Photoperiodic changes in adiposity increase sensitivity of female Siberian hamsters to systemic VGF derived peptide TLQP-21 2.155
Effect of TLQ-21 peripheral injection on food intake and reproduction mechanisms in female Siberian Hamsters 1.938
Selective VGF-peptide/s changes in human neurodegenerative diseases. 1.933
Novel VGF-derived peptides in homeostatic control: blood and tissue changes of the amidated NERP peptide/s upon salt loading and dehydration 1.909
Peptide products of the neurotrophin-inducible gene vgf are produced in human neuroendocrine cells from early development, and increase in hyperplasia and neoplasia 1.885
BTK inhibitors synergize with 5-FU to treat drug-resistant TP53-null colon cancers 1.865
Dynamic of TLQP-peptides upon fasting 1.821
In vitro and in vivo pharmacological role of TLQP-21, a VGF-derived peptide, in the regulation of rat gastric motor functions 1.781
Analysis of hypothalamic VGF-immunoreactivity in the Siberian Hamster. 1.768
HYPOTHALAMIC-Pituitary axis in aps i: novel autoantibody targets possibly related to endocrine disfunctions 1.721
Pro-VGF-derived peptides induce penile erection in male rats: possible involvement of oxytocin 1.672
Le malattie autoimmuni dell'ipofisi e dell'Ipotalamo 1.454
A role for VGF in the hypothalamic arcuate and paraventricular nuclei in the control of energy homeostasis 1.436
Gastric immunolocalization and plasma profiles of acyl-ghrelin in fasted and fasted-refed prepuberal gilts 1.432
P65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma 1.377
NPY and VGF Immunoreactivity Increased in the Arcuate Nucleus, but Decreased in the Nucleus of the Tractus Solitarius, of Type-II Diabetic Patients 1.353
Tissue cryoarraies: a novel approach to autoantibodies detection 1.257
Tunable, colour coded simultaneus viewing in multiple fluorescence: a novel approach to gene-product espression dynamics. 1.223
Median eminence dopaminergic nerve terminals: a novel target in autoimmune polyendocrine syndrome? 1.203
Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach 1.165
The novel neuroendocrine peptides “nerp-1” and “nerp-2”: changes in altered water balance 1.144
Differential expression and seasonal modulation of VGF peptides in sheep pituitary 1.127
Median eminence dopaminergic terminals: a novel autoimmune target 1.085
Median eminence dopaminergic terminals: a novel auto-immune target in neuro/endocrine disease 1.080
TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity. 1.012
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus 1.005
Embedding media for cryomicrotomy: an applicative reappraisal 998
Autoantibodies to anterior pituitary cells and hypothalamic neurons in a girl with type 1 autoimmune polyendocrinopathy (APECED), associated to growth and pubertal retardation 991
Autoimmune target within the hypothalamic median eminence in patients with a polyendocrine disease 984
VGF-DERIVED PEPTIDES AND THEIR BIOLOGICAL ACTIVITY 932
Equipment testing and tuning: the cold-knife cryomicrotome microm HM-560 859
Autoantibodies targets in the hypothalamic-hypophyseal complex: possibile role in type 1 autoimmune polyendocrinopaty with growth arrest 822
MODULAR MULTI-BAND FLUORESCENCE EXCITATION SYSTEM 800
VGF peptides upon osmotic stimuli: Changes in neuroendocrine regulatory peptides 1 and 2 in the hypothalamic-pituitary-axis and plasma 701
Autoantibodies to anterior pituitary cells and hypothalamic neurons in a girl with type I autoimmune polyendocrinopathy (APECED), associated to growth and pubertal retardation. 679
The "VGF" protein in rat adenohypophysis: sex differences and changes during the estrous cycle and after gonadectomy 584
Simultaneous dual-fluorochromes visualization for co-localization studies 528
Adjustable multi-band excitation and visualization / imaging system for simultaneous viewing multiple fluorescence (DEPOSITO BREVETTO INTERNAZIONALE PCT) 490
Ileal enteroglucagon cells after ileal-duodenal transposition in the rat. 446
Secretin-stimulated trypsin-like immunoreactivity in alcoholics 438
Layer separation of the human bowel for the study of regulatory peptides 425
Presence of PHI in the human intestine 412
The endogenous cannabinoid system protects against colonic inflammation 405
Distribution and molecular heterogeneity of galanin in human, pig, guinea pig, and rat gastrointestinal tracts. 403
Immunocytochemical evidence for the presence of gamma 1-MSH-like immunoreactivity in pituitary corticotrophs and ACTH-producing tumours. 391
Intramural distribution of neuron specific enolase (NSE) in the human gastrointestinal tract. 391
The use of crypt suspensions for endocrine cell quantification. 381
Processing, Distribution and Function of VGF, a Neuronal and Endocrine Peptide Precursor 377
Immunocytochemistry of serotonin-containing nerves in the human gut. 374
ACRYLAMIDE-INDUCED VISCERAL NEUROPATHY: EVIDENCE FOR THE INVOLVEMENT OF CAPSAICIN-SENSITIVE NERVES OF THE RAT URINARY BLADDER 371
QUANTIFICATION OF ENDOCRINE CELLS IN WHOLE INTESTINAL CRYPTS AND VILLI 369
Neuron specific enolase: a common marker for the endocrine cells and innervation of the gut and pancreas. 361
DIRECT EYE VISUALIZATION OF CY5 FLUORESCENCE FOR IMMUNOCYTOCHEMISTRY AND IN SITU HYBRIDIZATION 353
Intramural distribution of Met5-enkephalin-Arg6-Gly7-Leu8 in sphincter regions of the human gut. 352
Human distribution and release of a putative new gut hormone, peptide YY. 349
Effect of secretin on serum trypsin-like immunoreactivity in alcoholics 344
Mapping, quantitative distribution and origin of substance p- and VIP-containing nerves in the uvea of guinea pig eye. 344
Radioimmunoassay and intramural distribution of PHI-IR in human intestine. 344
EVIDENCE FOR THE PRESENCE OF S-100 PROTEIN IN THE GLIAL COMPONENT OF THE ENTERIC NERVOUS SYSTEM 343
Totale 186.476
Categoria #
all - tutte 246.468
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 246.468


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124.625 0 0 0 0 0 6.792 3.924 4.189 1.543 3.435 3.002 1.740
2021/20229.976 1.530 853 427 841 906 576 584 395 868 1.139 1.061 796
2022/202313.015 898 1.703 1.907 1.174 986 1.268 634 985 959 914 1.083 504
2023/202412.635 911 802 637 1.036 1.356 1.717 1.706 865 885 805 945 970
2024/202516.116 2.804 3.852 2.622 1.837 1.106 1.164 1.310 186 307 286 286 356
2025/20263.531 468 368 963 632 603 497 0 0 0 0 0 0
Totale 199.429